ClintTannerAllenMD

Otolaryngology (ENT) • Bethesda, MD

Head & Neck Oncologic Surgery, Laryngology & Voice Disorders

Assistant Professor of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Allen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Allen's full profile

Already have an account?

Office
6420 Rockledge Dr
Ste 4920
Bethesda, MD 20817
Phone+1 301-896-3331

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Otolaryngology - Head and Neck Surgery, 2007 - 2012
Texas A&M; Health Science Center College of MedicineClass of 2007

Certifications & Licensure

MD State Medical License 2013 - 2026
VA State Medical License 2022 - 2024
WA State Medical License 2012 - 2014
MO State Medical License 2007 - 2012
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Publications & Presentations

PubMed

163 citations
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.
Sarah Greene, Yvette Robbins, Wojciech K. Mydlarz, Angel P. Huynh, Nicole C. Schmitt
Clinical Cancer Research. 2020-03-15
169 citations
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.
Lillian Sun, Paul E. Clavijo, Yvette Robbins, Priya Patel, Jay Friedman
JCI Insight. 2019-04-22
27 citations
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells.
Maxwell Y Lee, Yvette Robbins, Cem Sievers, Jay Friedman, Houssein Abdul Sater
Journal for Immunotherapy of Cancer. 2021-03-01

Journal Articles

Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
Nicole C Schmitt, Clint T Allen, Clinical Cancer Research

Press Mentions

Precigen Achieves Significant Clinical Progress for UltraCAR-T® and AdenoVerse™ TherapiesNovember 4th, 2021
Arming Immune Foot Soldiers Against CancerMay 13th, 2020
NantKwest : Key Opinion Leader EventDecember 2nd, 2019
Join now to see all

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/clint-allen